KRAS Inhibitor Market By Cancer Type (Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others), By End-user (Hospitals, Clinic Laboratories, Cancer Research Institutes, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Nov 2024
- Report ID: 133937
- Number of Pages: 362
- Format:
-
-
-
- Novartis AG Company Profile
- Mirati Therapeutics
- Jemincare
- Innovent Biologics, Inc.
- Incyte
- Erasca
- BridgeBio Pharma
- Amgen
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible